safety of glp-1 receptor agonists Efficacy and Glucagon-Like Peptide-1 on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis GLP-1 receptor agonists are transforming
Description
Hadidchi and her team are ready to assist
Additionally, monocyte and macrophage marker cluster of differentiation 68 (Cd68) and monocyte chemoattractant protein-1 (Mcp-1) levels were lowered when treated with GIPR/GLP1R agonists
October 29, 2022
30 These advancements raise important questions about how multi-receptor agonists should be integrated into routine clinical care for adolescents and whether they could eventually replace more invasive treatments like bariatric surgery
Before beginning therapy with a GLP-1 receptor agonist, patients should be advised of potential adverse effects and any tips for mitigating them if they occur
Correlates of overweight and obesity in 5529 adolescents with type 1 diabetes: The T1D Exchange Clinic Registry
